Drug Shortage Report for MYLAN-LATANOPROST/TIMOLOL
| Report ID | 176221 |
| Drug Identification Number | 02373068 |
| Brand name | GD-LATANOPROST/TIMOLOL |
| Common or Proper name | GD-LATANOPROST/TIMOLOL |
| Company Name | MYLAN PHARMACEUTICALS ULC |
| Market Status | MARKETED |
| Active Ingredient(s) | LATANOPROST TIMOLOL |
| Strength(s) | 50MCG 5MG |
| Dosage form(s) | SOLUTION |
| Route of administration | OPHTHALMIC OPHTHALMIC |
| Packaging size | 2.5ML |
| ATC code | S01ED |
| ATC description | ANTIGLAUCOMA PREPARATIONS AND MIOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. |
| Anticipated start date | |
| Actual start date | 2022-11-21 |
| Estimated end date | Unknown |
| Actual end date | 2022-12-20 |
| Shortage status | Resolved |
| Updated date | 2023-01-17 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 85 ADVANCE ROAD ETOBICOKE, ONTARIO CANADA M8Z 2S6 |
| Company contact information | Mylan Pharmaceuticals ULC, 85 Advance Road, Etobicoke, ON, M8Z 2S6 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2023-01-17 | French | Compare |
| v3 | 2023-01-17 | English | Compare |
| v2 | 2022-11-29 | French | Compare |
| v1 | 2022-11-29 | English | Compare |
Showing 1 to 4 of 4